Celadon Pharmaceuticals (CEL) RNS Announcements

Add to Alert list
Date Time Source Announcement
18 Sep 2023 07:00 AM
RNS
Notice of Results and Investor Presentation
05 Sep 2023 07:00 AM
RNS
New Sales Contract with UK Pharmaceutical Company
01 Aug 2023 07:00 AM
RNS
Approval to roll-out chronic pain clinical trial
29 Jun 2023 05:30 PM
RNS
Result of AGM
05 Jun 2023 02:46 PM
RNS
Publication of Annual Report and Notice of AGM
05 Jun 2023 02:46 PM
RNS
Publication of Annual Report and Notice of AGM
05 Jun 2023 07:00 AM
RNS
Final Results for the year ended 31 December 2022
30 May 2023 07:00 AM
RNS
£7 Million Committed Credit Facility
26 May 2023 07:00 AM
RNS
Notice of Results and Investor Presentation
25 May 2023 07:00 AM
RNS
West Midlands Mayor Visits Celadon’s Facility
24 May 2023 07:00 AM
RNS
Inaugural Supply Contract Win
29 Mar 2023 11:05 AM
RNS
Second Price Monitoring Extn
29 Mar 2023 11:00 AM
RNS
Price Monitoring Extension
17 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
17 Mar 2023 02:05 PM
RNS
Second Price Monitoring Extn
17 Mar 2023 02:00 PM
RNS
Price Monitoring Extension
14 Mar 2023 03:01 PM
RNS
Successful Update to Home Office Licence
14 Mar 2023 02:05 PM
RNS
Second Price Monitoring Extn
14 Mar 2023 02:00 PM
RNS
Price Monitoring Extension
13 Mar 2023 04:40 PM
RNS
Second Price Monitoring Extn
13 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
13 Mar 2023 09:05 AM
RNS
Second Price Monitoring Extn
13 Mar 2023 09:00 AM
RNS
Price Monitoring Extension
10 Mar 2023 04:40 PM
RNS
Second Price Monitoring Extn
10 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
10 Mar 2023 02:05 PM
RNS
Second Price Monitoring Extn
10 Mar 2023 02:00 PM
RNS
Price Monitoring Extension
10 Feb 2023 02:15 PM
RNS
Notification of transaction by PDMR
19 Jan 2023 07:00 AM
RNS
Change of Website Address
16 Jan 2023 07:00 AM
RNS
Approval of GMP Registration by MHRA
13 Jan 2023 07:00 AM
RNS
Update on CFO Appointment
30 Dec 2022 07:00 AM
RNS
Results of Feasibility Study
22 Dec 2022 07:00 AM
RNS
Update on GMP Registration by MHRA
01 Nov 2022 07:00 AM
RNS
Appointment of CFO
29 Sep 2022 07:00 AM
RNS
Interim Report for six months ended 30 June 2022
12 Sep 2022 07:00 AM
RNS
Notice of Results
28 Jul 2022 07:00 AM
RNS
Appointment of Tessera Investment Management
27 Jun 2022 06:15 PM
RNS
Result of AGM
22 Jun 2022 07:00 AM
RNS
Business Update
31 May 2022 01:30 PM
RNS
Notice of AGM
29 Apr 2022 07:00 AM
RNS
Full year results
31 Mar 2022 08:08 AM
RNS
Holding(s) in Company
30 Mar 2022 04:41 PM
RNS
Second Price Monitoring Extn
30 Mar 2022 04:36 PM
RNS
Price Monitoring Extension
29 Mar 2022 08:00 AM
RNS
Change of Name
28 Mar 2022 08:04 AM
RNS
First Day of Dealings
25 Mar 2022 11:45 AM
RNS
Result of General Meeting
21 Mar 2022 08:30 AM
RNS
Holding(s) in Company
10 Mar 2022 01:58 PM
RNS
Director/PDMR Shareholding
28 Feb 2022 11:05 AM
RNS
Second Price Monitoring Extn

Celadon Pharmaceuticals Plc is a UK-based pharmaceutical company focused on researching, cultivating, manufacturing, and supplying breakthrough cannabis-based medicines, primarily for chronic pain. The company operates a large, licensed facility in the West Midlands with indoor hydroponic cultivation and an EU-GMP standard laboratory.

Celadon Pharmaceuticals' share price was cancelled on 8 August 2025.

UK 100